These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Diagnosis, treatment and control of Taenia solium cysticercosis. Garcia HH; Gonzalez AE; Gilman RH; Curr Opin Infect Dis; 2003 Oct; 16(5):411-9. PubMed ID: 14501993 [TBL] [Abstract][Full Text] [Related]
24. Zoonotic Taenia infections with focus on cysticercosis due to Taenia solium in swine and humans. Mendlovic F; Fleury A; Flisser A Res Vet Sci; 2021 Jan; 134():69-77. PubMed ID: 33321377 [TBL] [Abstract][Full Text] [Related]
25. [Paediatric neurocysticercosis: two case reports]. Frieiro-Dantas C; Serramito-García R; Reyes-Santías RM; Rico-Cotelo M; Allut AG; Gelabert-González M Rev Neurol; 2013 Jan; 56(2):86-90. PubMed ID: 23307354 [TBL] [Abstract][Full Text] [Related]
26. Human taeniasis/cysticercosis: a potentially emerging parasitic disease in Europe. Symeonidou I; Arsenopoulos K; Tzilves D; Soba B; Gabriël S; Papadopoulos E Ann Gastroenterol; 2018; 31(4):406-412. PubMed ID: 29991885 [No Abstract] [Full Text] [Related]
27. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Garcia HH; Nash TE; Del Brutto OH Lancet Neurol; 2014 Dec; 13(12):1202-15. PubMed ID: 25453460 [TBL] [Abstract][Full Text] [Related]
28. Distribution of Cruz-Rivera M; Torres J; Carrillo-Farga J; Wilkins PP; Flisser A; Mendlovic F J Parasitol; 2019 Aug; 105(4):642-650. PubMed ID: 31436487 [No Abstract] [Full Text] [Related]
31. Host immune responses during Taenia solium Neurocysticercosis infection and treatment. Prodjinotho UF; Lema J; Lacorcia M; Schmidt V; Vejzagic N; Sikasunge C; Ngowi B; Winkler AS; Prazeres da Costa C PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008005. PubMed ID: 32298263 [TBL] [Abstract][Full Text] [Related]
32. Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Ahmad R; Khan T; Ahmad B; Misra A; Balapure AK Parasitol Res; 2017 Jan; 116(1):21-33. PubMed ID: 27774576 [TBL] [Abstract][Full Text] [Related]
33. [Neurocysticercosis diagnosis and management in Peru]. Saavedra H; Gonzales I; Alvarado MA; Porras MA; Vargas V; Cjuno RA; Garcia HH; Martinez SM Rev Peru Med Exp Salud Publica; 2010; 27(4):586-91. PubMed ID: 21308200 [TBL] [Abstract][Full Text] [Related]
38. New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries. Carpio A; Fleury A; Kelvin EA; Romo ML; Abraham R; Tellez-Zenteno J Expert Rev Neurother; 2018 Oct; 18(10):743-747. PubMed ID: 30185077 [TBL] [Abstract][Full Text] [Related]
39. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after. Garcia HH; Gonzales I; Lescano AG; Bustos JA; Pretell EJ; Saavedra H; Nash TE; Epilepsia; 2014 Sep; 55(9):1452-9. PubMed ID: 25092547 [TBL] [Abstract][Full Text] [Related]
40. Neurocysticercosis and acquired cerebral toxoplasmosis in children. Mitchell WG Semin Pediatr Neurol; 1999 Dec; 6(4):267-77. PubMed ID: 10649835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]